Login
Register
Reset Password
Publish & Distribute
Publishing Solutions
Distribution Solutions
Subjects
Publications
Journals
Books
Proceedings
Publishers
Blog
Contact
Search
Cart
EUR
USD
GBP
English
English
Deutsch
Polski
Español
Français
Italiano
Home
Journals
Radiology and Oncology
Volume 49 (2015): Issue 4 (December 2015)
Open Access
Impact of comorbidity on the outcome in men with advanced prostate cancer treated with docetaxel
Andrej Zist
Andrej Zist
,
Eitan Amir
Eitan Amir
,
Alberto F. Ocana
Alberto F. Ocana
and
Bostjan Seruga
Bostjan Seruga
| Nov 27, 2015
Radiology and Oncology
Volume 49 (2015): Issue 4 (December 2015)
About this article
Previous Article
Next Article
Abstract
References
Authors
Articles in this Issue
Preview
PDF
Cite
Share
Published Online:
Nov 27, 2015
Page range:
402 - 408
Received:
May 05, 2015
Accepted:
Jul 19, 2015
DOI:
https://doi.org/10.1515/raon-2015-0038
Keywords
metastatic castration-resistant prostate cancer
,
comorbidity
,
chemotherapy
© 2015 Andrej Zist et al., published by De Gruyter Open
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Andrej Zist
Department of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia
Eitan Amir
Division of Medical Oncology and Haematology, Princess Margaret Cancer Centre, Toronto, Canada
Alberto F. Ocana
Medical Oncology Department and Translational Research Unit, Albacete University Hospital, Spain
Bostjan Seruga
Department of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia